期刊文献+

高迁移率蛋白B1介导Toll样受体信号通路的研究进展 被引量:9

Updates on the Pathways of Toll-Like Receptors Mediated by HMGB1
下载PDF
导出
摘要 高迁移率族蛋白B1(high mobility group box 1 protein,HMGB1)是核内一类非组蛋白DNA结合蛋白,属于损伤相关分子模式(damage-associated molecular patterns,DAMPs),参与DNA复制、重组、修复和基因转录调控等。HMGB1能通过Toll样受体(Toll-like receptor,TLR)等激活固有免疫以及诱导T细胞分化成熟启动适应性免疫应答,与多种自身免疫性疾病、炎症性疾病和肿瘤等关系密切。目前关于HMGB1介导TLR信号通路在某些疾病中的作用的研究较多,HMGB1介导Toll样受体信号通路参与多种病理过程具有广阔的临床前景。 High mobility group box 1 protein,a kind of damage-associated molecular patterns,is a group of nonhistone DNA- binding protein in the nuclear. It not only involves in DNA replication, recombination, repair, regulation of gene transcription,but also induces activation of innate immunity and T cell generation and activates the adaptive immune response through Toll-like receptor. It is also more closely related to autoimmune diseases,inflammatory diseases, tumors and so on. Currently there are many researches on the role of TLR-mediated HMGB1 signaling pathway in diseases, which is involved in a variety of pathological processes and has a broad clinical outlook.
出处 《现代检验医学杂志》 CAS 2017年第3期162-164,共3页 Journal of Modern Laboratory Medicine
关键词 高迁移率蛋白B1 TOLL样受体 信号通路 high mobility group box 1 protein toll-like receptor signaling pathway
  • 相关文献

参考文献1

二级参考文献11

  • 1Juan Vaz,Hamid Akbarshahi,Roland Andersson.Controversial role of toll-like receptors in acute pancreatitis[J].World Journal of Gastroenterology,2013,19(5):616-630. 被引量:17
  • 2Rebecca Siegel,Deepa Naishadham,Ahmedin Jemal.Cancer statistics, 2013[J]. CA: A Cancer Journal for Clinicians . 2013 (1)
  • 3Lei Zheng,Jing Xue,Elizabeth M. Jaffee,Aida Habtezion.Role of Immune Cells and Immune-Based Therapies in Pancreatitis and Pancreatic Ductal Adenocarcinoma[J].Gastroenterology.2013(6)
  • 4Minoti V. Apte,Jeremy S. Wilson,Aurelia Lugea,Stephen J. Pandol.A Starring Role for Stellate Cells in the Pancreatic Cancer Microenvironment[J].Gastroenterology.2013(6)
  • 5Kentaro Shikata,Toshiharu Ninomiya,Yutaka Kiyohara.Diabetes mellitus and cancer risk: Review of the epidemiological evidence[J].Cancer Sci.2012(1)
  • 6Daniel Ansari,Carlos Urey,Chinmay Gundewar,Monika Posaric Bauden,Roland Andersson.Comparison of MUC4 expression in primary pancreatic cancer and paired lymph node metastases[J].Scandinavian Journal of Gastroenterology.2013(10)
  • 7Daniel Ansari,Bobby Tingstedt,Roland Andersson.Pancreatic cancer – cost for overtreatment with gemcitabine[J].Acta Oncologica.2013(6)
  • 8Ilya Gukovsky,Ning Li,Jelena Todoric,Anna Gukovskaya,Michael Karin.Inflammation, Autophagy, and Obesity: Common Features in the Pathogenesis of Pancreatitis and Pancreatic Cancer[J].Gastroenterology.2013(6)
  • 9Volker Heinemann,Michael Haas,Stefan Boeck.Systemic treatment of advanced pancreatic cancer[J].Cancer Treatment Reviews.2011(7)
  • 10Kiyoshi Yoshikawa,Shuichi Mitsunaga,Taira Kinoshita,Masaru Konishi,Shinichiro Takahashi,Naoto Gotohda,Yuichiro Kato,Masaki Aizawa,Atsushi Ochiai.Impact of tumor‐associated macrophages on invasive ductal carcinoma of the pancreas head[J].Cancer Sci.2012(11)

共引文献4

同被引文献95

引证文献9

二级引证文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部